Experience the EOSTM Plug in Action

ArtVentive has developed the Endoluminal Occlusion System (EOSTM), a plug, achieving immediate, complete, and permanent occlusion of peripheral vasculature.

About ArtVentive

About ArtVentive

Learn more about the company behind our innovative success

Meet EOS

 Meet the EOSTM Plug

View the vascular plug that redefines peripheral embolization

Case Studies

Case Studies

Explore selected cases, and see how the EOSTM Plug improves clinical outcomes

News and Events

ArtVentive Management Releases Strategic Growth Plan; Reviews Commercial Progress

ArtVentive Medical Group, Inc. (“ArtVentive”) announced today its strategic sales plan for the company’s growth and highlighted recent commercialization progress in the United States and Europe. Dr, Leon Rudakov, ArtVentive’s founder and Chief Technology Officer, and Bill Olson, newly appointed Chief Executive Officer, identified an innovative sales and marketing strategy for ArtVentive’s revolutionary blood vessel occlusion device EOS™. Read More.

ArtVentive Medical Group, Inc. Files Form 15 with the Securities and Exchange Commission Focusing on Rapid Sales Growth Not Public Reporting

ArtVentive Medical Group, Inc. (“ArtVentive”) announced today that it filed a Form 15 with the Securities and Exchange Commission relieving it of all reporting requirements with the Securities and Exchange Commission. Read More.

Visit ArtVentive at GEST Europe 2017 in Florence

ArtVentive will attend GEST Europe in Florence, Italy from May 31 to June 3 Visit us at booth #9 to learn more about the EOS™ Plug and let us demonstrate its unique ability to immediately occlude blood flow in veins, arteries and tubes in the human body. Read More.